XML 31 R20.htm IDEA: XBRL DOCUMENT v3.25.2
Segment Information
 3 Months Ended
Jun. 29, 2025
Segment Reporting [Abstract]  
Segment Information Segment Information
Effective beginning with the first fiscal quarter of fiscal 2026, we realigned our reporting segments to reflect organizational changes made and to reflect the way we manage our operations and allocate resources. We believe this realignment better reflects the value our company provides to our customers and our evolution from a bulk commodity distributor into a specialty ingredients company. In fiscal 2026, we organize and manage our business by the following three segments, each of which meets the definition of reportable segments under ASC 280-10, Segment Reporting: Water Treatment, Food & Health Sciences, and Industrial Solutions. These segments are defined primarily by product and type of customer.
Our chief operating decision-maker (CODM), who is our President and Chief Executive Officer, regularly reviews the consolidated financial statements in their entirety and financial information at the reportable segment level. The CODM uses operating income and considers budget-to-actual variances on a quarterly basis when making decisions about the allocation of operating and capital resources to each segment. The CODM also uses segment operating income for evaluating pricing strategy, to assess the performance of each segment by comparing the results of each segment with one another, and in determining the compensation of certain employees. The CODM has ultimate responsibility for enterprise decisions and making resource allocation decisions for the Company and the segments.
•Our Water Treatment segment specializes in providing chemicals, products, equipment, services and solutions for potable water, municipal and industrial wastewater, industrial process water, non-residential swimming pool water and agricultural water. This segment has the resources and flexibility to treat systems ranging in size from a single small well to a multi-million-gallon-per-day facility.
•Our Food & Health Sciences segment specializes in processing and formulation solutions as well as ingredient distribution to manufacturers in the nutrition, pharmaceutical, food, and agricultural markets. This segment offers a
diverse product portfolio including base chemistry, acid based reactions, minerals, vitamins and amino acids, excipients, botanicals and herbs, sweeteners and enzymes, fertilizers, and food-grade and pharmaceutical salts and ingredients.
•Our Industrial Solutions segment specializes in providing industrial chemicals, products and services to industries such as industrial manufacturing, chemical processing, electronics, energy, plating, and surface finishing. This segment’s principal products are acids and alkalis.
The accounting policies of the segments are the same as those described in the summary of significant accounting policies. Product costs and expenses for each segment are based on actual costs incurred along with cost allocations of shared and centralized functions.
There are no intersegment sales and no operating segments have been aggregated.
In fiscal 2026 and 2025, none of our customers accounted for 10% or more of our total sales.
Summarized financial information for our reportable segments is presented and reconciled to consolidated financial information in the following tables:
(In thousands)Water
Treatment		Food & Health SciencesIndustrial SolutionsTotal
Three months ended June 29, 2025:
Sales$149,566 $89,177 $54,529 $293,272 
Cost of sales - materials89,159 65,814 42,848 197,821 
Cost of sales - operational overhead16,660 4,015 2,414 23,089 
Gross profit43,747 19,348 9,267 72,362 
Selling, general, and administrative expenses19,085 8,381 3,563 31,029 
Operating income24,662 10,967 5,704 41,333 
Interest expense, net(3,269)
Other income942 
Income tax expense(9,831)
Net income29,175 
Identifiable assets*569,354 249,315 132,575 951,244 
Capital expenditures7,560 3,013 2,971 13,544 
Depreciation and amortization6,904 3,200 2,187 12,291 
Three months ended June 30, 2024:
Sales$117,176 $85,093 $53,610 $255,879 
Cost of sales - materials65,997 61,547 41,941 169,485 
Cost of sales - operational overhead15,971 3,643 2,125 21,739 
Gross profit35,208 19,903 9,544 64,655 
Selling, general, and administrative expenses14,079 7,365 3,420 24,864 
Operating income21,129 12,538 6,124 39,791 
Interest expense, net(1,263)
Other income159 
Income tax expense(9,808)
Net income28,879 
Identifiable assets*300,313 241,527 130,163 672,003 
Capital expenditures6,121 2,161 2,367 10,649 
Depreciation and amortization4,171 3,089 2,069 9,329 
*Unallocated assets not included, consisting primarily of cash and cash equivalents, prepaid expenses, and non-qualified deferred compensation plan assets of $37.0 million at June 29, 2025 and $30.7 million at June 30, 2024.